Advancing new Ewing sarcoma therapy
From the article
Xiaodong Wang, PhD, and Pengda Liu, PhD, were awarded a $3.8 million NCI grant to develop a promising targeted treatment for a rare and aggressive pediatric cancer. The post Advancing new Ewing sarcoma therapy appeared first on UNC Lineberger Comprehensive Cancer Center .
Continue reading on pharmacy.unc.eduYou might also wanna read
A Multicenter Randomized Open-Label Trial Evaluating MRD-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
clinicaltrials.gov·1d ago
Jackson Laboratory and Broad Institute receive $34.5M ARPA-H award for pediatric epilepsy gene editing platform
The Jackson Laboratory (JAX), in partnership with the Broad Institute and other collaborators, has been selected for an up to $34.5 million
jax.org·3h ago
New cancer drug trial offers hope for patients with rare aggressive tumour
Reading Chronicle·2d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·3d ago
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer | NEJM
nejm.org·1mo ago
July 15 Deadline for Pediatric Brain Tumors Young Investigator Award – ASCO
OncoDaily·6h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.